Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA – first update
Testo completo
Documenti correlati
The following non-mutually exclusive approaches for vaccine deployment can be considered when building vaccination strategies, taking into account different levels of vaccine
Modelling scenarios that consider vaccine uptake (including ‘additional dose’ and ‘booster’ vaccinations), vaccine effectiveness, waning vaccine-induced immunity, vaccination
Booster dose to people aged ≥65 years, LTCF residents, LTCF staff, individuals who received a single dose of COVID-19 Vaccine Janssen, people aged ≥18 years who share a
Modelling scenarios that consider vaccination coverage, vaccine effectiveness, natural immunity and population contact rates—in the context of continued Delta circulation—indicate
Since the last ECDC threat assessment brief ‘Emergence of SARS-CoV-2 B.1.617 variants in India and situation in the EU/EEA’ [1] and as further described in the ECDC rapid
In summary, the probability of the risk of COVID-19 incidence rising to levels that require stricter response measures, as a consequence of lifting/adjusting community level
Increased transmission rates associated with variants of concern also mean that, even in the absence of a higher severity of the disease, the larger number of COVID-19 cases,
In countries observing high or sustained increase in notification rates, or high test positivity, but with high testing rates and transmission occurring primarily in young